Publication | Closed Access

High level prokaryotic expression of anti-Müllerian inhibiting substance type II receptor diabody, a new recombinant antibody for in vivo ovarian cancer imaging

GynecologyNew Recombinant AntibodyAntibody EngineeringTumor TargetingMedicineRadiation OncologyMolecular ImagingVivo Ovarian CancerEndocrine-related CancerOvarian Cancer